Caris Life Sciences Inc (CAI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2024 | 12-2023 | 09-2021 | 06-2021 | 03-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -177,214 | -341,415 | 124,838 | 73,683 | 35,740 |
| Depreciation Amortization | 32,637 | 54,379 | 93,565 | 59,859 | 29,581 |
| Income taxes - deferred | N/A | N/A | 1,201 | -3,205 | -940 |
| Accounts receivable | -16,904 | N/A | -18,126 | -2,390 | 488 |
| Accounts payable and accrued liabilities | 2,623 | N/A | N/A | N/A | N/A |
| Other Working Capital | -5,301 | -7,129 | 70,051 | 48,452 | 20,481 |
| Other Operating Activity | 27,308 | 18,065 | -11,852 | -14,335 | -9,561 |
| Operating Cash Flow | $-136,851 | $-276,100 | $259,677 | $162,064 | $75,789 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 61,376 | N/A | -84 | -3,477 | -2,529 |
| PPE Investments | -4,326 | -22,319 | -744,094 | -225,346 | -142,864 |
| Other Investing Activity | 0 | 237,093 | 1,252 | 1,252 | 1,285 |
| Investing Cash Flow | $57,050 | $214,774 | $-742,926 | $-227,571 | $-144,108 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 199,978 | N/A | 1,221,888 | 260,000 | 141,000 |
| Debt Repayment | -110 | N/A | -707,890 | -183,743 | -59,887 |
| Common Stock Issued | 603 | N/A | 1,764 | 1,697 | 1,499 |
| Common Stock Repurchased | N/A | N/A | -12,788 | -12,788 | -12,788 |
| Dividend Paid | N/A | 0 | -22,217 | -14,805 | -7,399 |
| Other Financing Activity | -492 | 10,132 | -1,584 | 0 | 0 |
| Financing Cash Flow | $199,979 | $10,132 | $479,173 | $50,361 | $62,425 |
| Exchange Rate Effect | 13 | 62 | -114 | -127 | -8 |
| Beginning Cash Position | 60,007 | 111,139 | 66,502 | 66,502 | 66,502 |
| End Cash Position | 180,198 | 60,007 | 62,312 | 51,229 | 60,600 |
| Net Cash Flow | $120,191 | $-51,132 | $-4,190 | $-15,273 | $-5,902 |
| Free Cash Flow | |||||
| Operating Cash Flow | -136,851 | -276,100 | 259,677 | 162,064 | 75,789 |
| Capital Expenditure | -4,326 | N/A | -821,900 | -276,726 | -171,647 |
| Free Cash Flow | -141,177 | -276,100 | -562,223 | -114,662 | -95,858 |